Detalhe da pesquisa
1.
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial.
Ann Oncol
; 22(11): 2476-2481, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21436186
2.
Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer.
Bone Marrow Transplant
; 41(6): 555-62, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18037940
3.
[Germ cell testicular tumors: understanding the kinetics of serum human chorionic gonadotropin during chemotherapy]. / Tumeurs germinales du testicule : comprendre les cinétiques de la gonadotrophine chorionique humaine (hCG) sérique sous chimiothérapie.
Ann Biol Clin (Paris)
; 66(5): 515-21, 2008.
Artigo
em Francês
| MEDLINE | ID: mdl-18957340
4.
[Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy]. / Tumeurs germinales non séminomateuses du testicule : comprendre les cinétiques d'alpha-foetoprotéine (AFP) sous chimiothérapie.
Ann Biol Clin (Paris)
; 66(5): 523-30, 2008.
Artigo
em Francês
| MEDLINE | ID: mdl-18957341
5.
Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: a randomized phase 2 trial.
Crit Rev Oncol Hematol
; 64(1): 64-72, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17317205
6.
A study from the EORTC new drug development group: open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancer.
Eur J Cancer
; 42(2): 200-4, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16337787
7.
Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.
J Clin Oncol
; 13(10): 2629-36, 1995 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-7595717
8.
Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer.
J Clin Oncol
; 13(7): 1564-71, 1995 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-7541448
9.
A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
J Clin Oncol
; 8(6): 1063-9, 1990 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-2140854
10.
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial.
J Clin Oncol
; 20(14): 3114-21, 2002 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12118025
11.
Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix.
J Clin Oncol
; 17(10): 3136-42, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10506610
12.
Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
J Clin Oncol
; 14(4): 1136-45, 1996 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-8648368
13.
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. The French Federation of Cancer Centers experience.
Eur J Cancer
; 27(12): 1690-4, 1991.
Artigo
em Inglês
| MEDLINE | ID: mdl-1782084
14.
Tetracosactrin vs. methylprednisolone in the prevention of emesis in patients receiving FEC regimen for breast cancer.
Eur J Cancer
; 27(7): 849-52, 1991.
Artigo
em Inglês
| MEDLINE | ID: mdl-1834115
15.
Fotemustine plus dacarbazine for malignant melanoma.
Eur J Cancer
; 28A(11): 1807-11, 1992.
Artigo
em Inglês
| MEDLINE | ID: mdl-1389514
16.
Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer.
Eur J Cancer
; 40(7): 1021-30, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15093577
17.
Hepatoid adenocarcinoma of the lung: report of a case of an unusual alpha-fetoprotein-producing lung tumor.
Am J Surg Pathol
; 21(9): 1113-8, 1997 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-9298890
18.
Premenopausal patients with node-positive resectable breast cancer. Preliminary results of a randomised trial comparing 3 adjuvant regimens: FEC 50 x 6 cycles vs FEC 50 x 3 cycles vs FEC 75 x 3 cycles. The French Adjuvant Study Group.
Drugs
; 45 Suppl 2: 38-45, 1993.
Artigo
em Inglês
| MEDLINE | ID: mdl-7693420
19.
p53 gene alterations are associated with a decreased responsiveness to neoadjuvant chemotherapy in human breast cancer.
Int J Oncol
; 10(6): 1203-7, 1997 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21533505
20.
Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer.
Cancer Chemother Pharmacol
; 52(2): 99-107, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12768319